Literature DB >> 2656879

Countrywide epidemics of Chlamydia pneumoniae, strain TWAR, in Scandinavia, 1981-1983.

J T Grayston1, C Mordhorst, A L Bruu, S Vene, S P Wang.   

Abstract

There was a large increase in incidence of reported cases of ornithosis in Norway, Sweden, and Denmark in 1981-1983. Serologic evidence indicated that the epidemic was caused by the newly described Chlamydia organism, C. pneumoniae, strain TWAR. When serum samples that had been shown to contain Chlamydia complement fixing antibodies were tested by the microimmunofluorescence method with TWAR antigen, 49%-71% showed evidence of current TWAR infection during the epidemic years compared with 10%-20% in nonepidemic years.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2656879     DOI: 10.1093/infdis/159.6.1111

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  23 in total

1.  Seroepidemiology of Chlamydia pneumoniae in Japan between 1991 and 2000.

Authors:  N Miyashita; H Fukano; K Yoshida; Y Niki; T Matsushima
Journal:  J Clin Pathol       Date:  2002-02       Impact factor: 3.411

2.  Outbreak of Chlamydia pneumoniae infection in four farm families.

Authors:  C H Mordhorst; S P Wang; J T Grayston
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-07       Impact factor: 3.267

Review 3.  Chlamydial infections.

Authors:  J Schachter
Journal:  West J Med       Date:  1990-11

4.  Chlamydia pneumoniae, strain TWAR, as the cause of an outbreak in a boys' school previously called psittacosis.

Authors:  J V Pether; S P Wang; J T Grayston
Journal:  Epidemiol Infect       Date:  1989-10       Impact factor: 2.451

5.  Acute intrahepatic cholestasis accompanied with Chlamydophila pneumoniae infection.

Authors:  Megumi Toyoda-Akui; Hiroaki Yokomori; Fumihiko Kaneko; Yuki Shimizu; Hajime Takeuchi; Kumiko Tahara; Hide Yoshida; Hirobumi Kondo; Tadashi Motoori; Makoto Ohbu; Masaya Oda; Toshifumi Hibi
Journal:  Med Mol Morphol       Date:  2011-03-23       Impact factor: 2.309

6.  Prevalence of antibodies to Chlamydia pneumoniae in a pediatric hospital population in Belgium.

Authors:  L Van Renterghem; A M Van den Abeele; G Claeys; J Plum
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-05       Impact factor: 3.267

7.  Use of HL cells for improved isolation and passage of Chlamydia pneumoniae.

Authors:  L D Cles; W E Stamm
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

8.  Ofloxacin versus standard therapy in treatment of community-acquired pneumonia requiring hospitalization. Pneumonia Study Group.

Authors:  J F Plouffe; M T Herbert; T M File; I Baird; J N Parsons; J B Kahn; K T Rielly-Gauvin
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

9.  The incidence of Chlamydia pneumoniae lower respiratory tract infections among university students in northern California.

Authors:  D K Katzman; A C Tipton; I F Litt; I M Friedman; R W Emmons; J Schachter
Journal:  West J Med       Date:  1991-08

10.  Similarity of Chlamydia pneumoniae strains in the variable domain IV region of the major outer membrane protein gene.

Authors:  C A Gaydos; T C Quinn; L D Bobo; J J Eiden
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.